Search

The University of Texas Southwestern Medical Center and Parkland Health are consulting the people of the Dallas area on participating in a trauma research study to investigate using one dose of fresh frozen plasma (FFP), the colorless fluid part of blood, to treat patients who suffered a traumatic brain injury.

The outbreak of measles that started in West Texas in January and spread to other regions and states has focused renewed attention on a childhood disease that had been eliminated in the United States in recent decades.

Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.

Scientists at UT Southwestern Medical Center, working with other U.S. researchers, have uncovered the structure of a key cell membrane protein in a bacterial model for Chlamydia trachomatis, the cause of the world’s most common bacterial sexually transmitted infection (STI).

A UT Southwestern research team has catalogued gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchene muscular dystrophy (DMD) in humans.

Artificial intelligence is rapidly reshaping the landscape of health care, revolutionizing scientific discovery, drug development, diagnosis and treatment, as well as health care delivery operations. As with any emerging technology, its success lies in its implementation, and The University of Texas System is committed to harnessing AI’s potential for the ultimate benefit of patients while ensuring its ethical and responsible use.

A study of patients resuscitated from out-of-hospital cardiac arrest shows that women have a lower likelihood of survival compared with men and are less likely to receive procedures commonly administered following cardiac arrest.

A study by researchers revealed that gut bacteria can penetrate tumor cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.

Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.